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Abstract
Background and purpose: Coronary chronic total occlusion (CTO) is the last stage of coronary artery
atherosclerosis. Percutaneous coronary intervention (PCI) is a therapeutic procedure used to recanalize vessels with
total occlusion. However, successful recanalization of CTO is still not optimal, and the key influence factors are still
uncertainty. Therefore, a scientific evaluation on the effective of PCI for CTO treatment is necessary.
Methods: Relevant studies of PCI treatment for CTO were examined. Data were extracted and assessed by two
independent clinical experts. Embase, PubMed and Medline et al. were used as database. The main research key
words include “CTO”, “PCI”, “Stent”, “Reopen”, “long-term”, “follow-up” and “outcome”. Quality assessment was
carried out according to the Cochrane Handbook. The selected data were pooled and analyzed using fixed-effect
model and random-effect model. Heterogeneity was assessed using the I2 test, Q test, L’abbe and Galbraith.
Comprehensive Meta -Analysis 2.0 and Metanalysis 1.0 were used for statistics analysis in this research.
Results: A total of 16 articles involving 6695 cases in successful CTO recanalization (CTO success group) and
2370 cases in failed CTO recanalization(CTO failure group) were included in this research. Low CTO success was
associated with elder age, previous coronary artery bypass graft surgery (CABG) history, multi-vessel diseases and
right coronary artery disease lesion. Six follow-up variables including major adverse cardiac events (MACE), recurrent
myocardial infarction (MI), all-cause death, incidence of angina, subsequent CABG and cumulative survival rate were
found significantly reduced associated with CTO success.
Conclusions: Clinical baseline characteristics such as age, previous CABG history and lesion baseline characteristics
such as lesion length, multi-vessel diseases might be important factors influencing the successful rate of CTO
recanalization. Compared to CTO failure patients, all six follow-up variables showed advantage for CTO success patients.
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Background
Coronary chronic total occlusion (CTO) is the last stage
of coronary artery atherosclerosis, accounting for one
third of the disease confirmed by coronary angiography
[1]. CTO exists in about 50% of patients with coronary
artery disease, which is often accompanied by complex
lesions, in about 15% patients as reported, revealed by
coronary angiography [2]. This disease can result in myo-
cardium ischemia, myocardiolysis, reduction of the num-
ber of myocardial cells, ventricular remodeling which lead
to decreased myocardium contractile, reduction of qua-
lity of life and poor prognosis [3]. Medication alone for
CTO treatment does reduce the clinical symptom, but
it has little effect on the long-term heart function and
the improvement of the patients’ survival rate. Percutan-
eous coronary intervention (PCI) is a therapeutic proced-
ure not only used to recanalize vessels with total occlusion
[4], but also widely used in other aspects such as increase
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blood flow reperfusion, improve myocardial contractile
and pump function [5], inhibit left ventricular remodeling
and decrease adverse cardiac events [6]. However, PCI
is considered not suitable for CTO lesions because of
the lack in strong backup support by the guiding ca-
theters or the difficulty in taking the contralateral cor-
onary angiograms [7]. The success rate of CTO patients
by PCI procedure is lower than that in non-CTO pa-
tients [8]. Revascularization for CTO lesions [9] is more
difficult and influenced by baseline clinical characte-
ristics, lesions level, intervention equipments and the
manipulation techniques [10]. With the development
of interventional technologies and physician’s mani-
pulation techniques, the successful rate of PCI pro-
cedure on CTO lesions is significantly increased [8].
However, CTO recanalization is still accepted as an
extremely challenging procedure in cardiovascular PCI
treatments.
The success of the recanalization for CTO in coronary
interventions is vital [11]. However, the long-term out-
comes such as cumulative survival rate, major adverse
cardiac events (MACE), incidence of restenosis and
reocclusion are still under debate based on different pro-
cedures and techniques [12]. Therefore, it is critical to
scientifically evaluate the effectiveness and influential
factors for CTO interventional treatment.
In this study, publications on PCI procedure in CTO
patients were systematically reviewed [13] and suggested
potential influential factors that influenced successful
rate and outcomes for PCI procedure [14].
Methods
Selection criteria for articles
Two investigators independently searched Embase,
PubMed, Medline, Ovid, CCTR, CNKI, CMBdisc, and
with additional manual search for related meeting abs-
tracts and websites including American Heart Association
American College of Cardiology, European Society of
Cardiology, and national postgraduate thesis pool (from
January 1990 to December 2009). The main research key
words include “CTO”, “PCI”, “Stent”, “Reopen”, “long-
term”, “follow-up” and “outcome”. No language restric-
tions were used. The inclusion criteria for selected studies
comprised: 1) patients with CTO diseases, 2) comparisons
of recanalization after PCI and unsuccessful recanalization
and 3) the follow-up period of articles were at least one
year. Studies with incomplete data or cases number less
than 50 were excluded from the analysis.
Figure 1 Pooled results of the weighted mean difference of age of patients in CTO success groups and CTO failure groups.
Figure 2 Pooled results of the weighted mean difference of lesion length of patients in CTO success groups and CTO failure groups.
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Data extraction
Clinical results with prespecified data forms were se-
lected by two independent investigators. Meta-analysis
was conducted by two independent clinical experts and
the data was pooled by fixed-effect model and random-
effect model [15].
Quality assessment
Two independent investigators assessed the quality of
eligible articles according to the Cochrane Handbook
[16] with established methods. It includes 5 items: (i)
Sequence generation; (ii) Allocation sequence conceal-
ment; (iii) Blinding of participants, personnel and outcome
assessors; (iv) Incomplete outcome data; (v) Selective out-
come reporting.
Statistics analysis
The 95% confidence interval (CI) were calculated from
abstracted dichotomous data of each study and pooled
according to fixed-effects (inverse-variance weighted)
and random-effects (DerSimonian and Laird) models.
Statistical heterogeneity was assessed with Cochran’s Q
via a chi-square test and quantified with the I2 test, P <
0.10 and I2 > 50% suggesting significant heterogeneity,
I2 ≤ 25% considering low heterogeneity. Searching Soft-
ware for analysis were Comprehensive Meta-Analysis 2.0
and Metanalysis 1.0.
Results
A total of 16 reports [17-32] during 1990 and 2009 (ran-
domized controlled trials and retrospective studies etc.)
were included in consistency with the selection criteria.
Totally 6695 cases in successful CTO recanalization
(CTO success group) and 2370 cases in failed CTO re-
canalization (CTO failure group) were included in this
study.
Influential factors for CTO recanalization
In order to compare clinical and lesion baseline charac-
teristics between CTO success group and CTO failure
Figure 3 Pooled results of the effect of the history of CABG on patients in CTO success groups and CTO failure groups.
Figure 4 Pooled results of the effect of multi-vessel diseases on patients in CTO success groups and CTO failure groups.
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group, meta-analysis was performed on the studies of
CTO revasculization with mean successful rate of 73.9%
for CTO recanalization. Eight clinical baseline charac-
teristics (including age, gender, hypertension, hyperli-
pidemia, diabetes mellitus, smoker, previous myocardial
infarction history, previous coronary artery bypass graft
surgery (CABG) history) and six lesion baseline charac-
teristics (lesion length, left ventricular ejection fraction,
multi-vessel coronary disease, left anterior descending
artery lesion, circumflex artery lesion, right coronary
artery disease lesion) were analyzed to assess discrepan-
cies between two treatment groups. Among these,
weighted average age difference between two groups was
0.083 (95% CI, 0.132 ~ 0.034, P = 0.001, heterogeneity,
Q = 31.571, P = 0.005, I2 = 50.655%) (Figure 1), weighted
average lesion length difference was −0.782 (95% CI, -1.499
to −0.065, P = 0.033, Q = 39.806 P < 0.001, I2 = 94.976%,
Figure 2). The low CTO success rate was associated with
previous CABG history (OR 0.707, 95% CI, 0.578 to 0.865,
P = 0.001, Q = 1.962 P = 0.854, I2 = 0.00%, Figure 3) and
multi-vessel diseases (OR, 0.649, 95% CI, 0.554 to 0.761,
P < 0.001, Q = 26.943 P = 0.029, I2 = 44.326%, Figure 4).
The other factors including gender, hypertension, hyper-
lipidemia, diabetes mellitus, smoker, previous myocardial
infarction history, left ventricular ejection fraction, left an-
terior descending artery lesion and circumflex artery le-
sion did not affect the recanalization rate of PCI on CTO
(P > 0.05).
The long term effect of PCI on CTO recanalization
A total of 16 articles were studied on long term out-
comes (follow up for more than one year) between CTO
success group and CTO failure group. Six follow up
variables including MACE, MI, all-cause death, angina
pectoris, subsequent CABG and accumulative survival
rate were analyzed. CTO success rate was associated with
significant reduction in MACE (OR, 0.689, 95% CI, 0.488
to 0.971, P = 0.034, Q = 41.951 P < 0.001, I2 = 76.163%,
Figure 5 Pooled results of major adverse cardiac events of patients in CTO success groups and CTO failure groups.
Figure 6 Pooled results of recurrent myocardial infarction of patients in CTO success groups and CTO failure groups.
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Figure 5), MI (OR, 0.578, 95% CI, 0.387 to 0.864,
P = 0.008, Q = 11.80 P = 0.107, I2 = 40.580%, Figure 6), all-
cause death (OR, 0.501, 95% CI, 0.384 to 0.654, P < 0.001,
Q = 28.283 P = 0.012, I2 = 51.02%, Figure 7), incidence
of angina (OR, 0.477, 95%CI, 0.340 to 0.670, P < 0.001,
Q = 12.977 P = 0.043, I2 = 53 .764%, Figure 8), subsequent
CABG (OR, 0.212, 95% CI, 0.175 to 0.257,P < 0.001,
Q = 9.873 P = 0.452, I2 = 0.00%, Figure 9) and cumula-
tive survival rate (hazard ratio (HR), 0.595, 95% CI, 0.488
to 0.791, P < 0.001, Q = 11.714 P = 0.039, I2 = 57.317%,
Figure 10).
Discussion
In this study, a scientific evaluation on the effective of
PCI for CTO treatment was carried out. A total of 16 ar-
ticles involving 6695 cases in successful CTO recanaliza-
tion (CTO success group) and 2370 cases in failed CTO
recanalization (CTO failure group) were included in this
research. All the articles were used to identify the factors
that influenced the PCI procedure outcome leading to a
successful CTO recanalization or failed CTO recanaliza-
tion. Finally, the clinical baseline characteristics such as
age, previous CABG history and lesion baseline charac-
teristics such as lesion length, multi-vessel diseases were
considered being the important factors influencing the
successful rate of CTO recanalization. Compared to
CTO failure patients, the six follow-up variables (MACE,
recurrent myocardial infarction, all-cause death, recur-
rent angina pectoris, subsequent CABG and accumu-
lated survival rate) showed advantage for CTO success
patients.
A lot of strategies and devices have been developed for
a cure of CTO, but the success rate for each treatment
is not consistent [33]. Previous study reveals that PCI
Figure 7 Pooled results of all-cause death of patients in CTO success groups and CTO failure groups.
Figure 8 Pooled results of recurrent angina of patients in CTO success groups and CTO failure groups.
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significantly improved both the local and global function
of the left ventricle in CTO patients [34]. Such proced-
ure is beneficial for the symptom in selected patients
[35]. However, NCDR (National Cardiovascular Data
Registry) suggested that the attempt rate of PCI on CTO
have not changed between 2004 and 2009 in the U.S.,
even though there are significant advance in the tech-
niques in this area [36], indicating that risks under such
procedure and factors affecting the success rate existed.
Although the use of PCI for CTO increases recently
[37], little systematic study directly compared the failed
and success surgery cases with successful recanalization
to identify the important factors under PCI. In this study,
eight clinical baseline characteristics (age, gender, hyper-
tension, hyperlipidemia, diabetes mellitus, smoker, previ-
ous myocardial infarction history and CABG history) and
the and six lesion baseline characteristics (lesion length,
left ventricular ejection fraction, multi-vessel coronary dis-
ease, left anterior descending artery lesion, Circumflex ar-
tery lesion and right coronary artery disease lesion) were
revealed by directly compared the failed and success
surgery cases with successful recanalization. The fac-
tors such as age, previous CABG history, lesion length
and multi-vessel diseases might be important for the
successful rate of CTO recanalization. Long-term pa-
tency after recanalization of CTO in patients with an-
gina pectoris is associated with improvement in global
and regional left ventricular function [38]. BEPM Claessen
et al., [39] revealed that the presence of a CTO is asso-
ciated with long-term mortality. In this study, six follow
up variables including MACE, MI, all-cause death, angina
pectoris, subsequent CABG and accumulative survival
rate were analyzed by meta-analysis. CTO success was
found to be associated with significant benefit in all these
factors (Table 1), which were consistent with previous
studies.
Although intervention studies that contain only ran-
domized trials as observational studies are not designed
for causal inference, observational studies itself also pro-
vide information that may suggest important message in
certain circumstance [40]. Compared to the patients in
CTO success group in our study, patients in CTO failure
Figure 9 Pooled results of subsequent CABG of patients in CTO success groups and CTO failure groups.
Figure 10 Pooled results of long-term survival rate of patients in CTO success groups and CTO failure groups.
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group were aged with severe lesion length and multi-
vessel diseases. These negative effects made their cases
more complicated and leaded to complications as well
as the end of procedure ahead of time. These factors
might be confounding variables for the analysis of the
long term effects after PCI procedure. However, the re-
sult of clinical baseline characteristics such as age, previ-
ous CABG history, lesion length and multi-vessel diseases
were not specific. There was no conclusion on how long
of lesion length could be benefit for CTO recanalization,
or how old of the patients will have higher successful rate
of CTO recanalization. Moreover, limitations also existed
in this study such as no bias test and text discrepancy.
Meanwhile, a subgroup analysis of time effect on the in-
volved studies was necessary.
Conclusions
The factors including age and CABG history as well as
the baseline lesion level (lesion length and multi-vessel
diseases) might be the important factors influencing the
successful rate of CTO recanalization. The in-hospital
mortality, MACE, and incidence of subsequent CABG
for PCI procedure were significantly lower in the CTO
success group compared with those in the CTO failure
group. All six follow up variables (MACE, recurrent myo-
cardial infarction, all-cause death, recurrent angina pec-
toris, subsequent CABG and accumulated survival rate)
showed an advantage for CTO patients with a successful
recanalization of occlusions.
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